AML digital therapeutic lands Breakthrough Device Designation
Blue Note Therapeutics has announced the status has been granted to BNT200, a device to treat anxiety and depression in acute myeloid leukemia patients.
Source: outsourcing-pharma.com
Stay updated with breaking news from Does Blue Note. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Blue Note Therapeutics has announced the status has been granted to BNT200, a device to treat anxiety and depression in acute myeloid leukemia patients.